封面
市場調查報告書
商品編碼
1980195

胎兒監護市場規模、佔有率、成長及全球產業分析:按類型、應用和地區分類的洞察,2026-2034 年預測

Fetal Monitoring Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034

出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

胎兒監護市場的成長要素

全球胎兒監護市場預計到 2025 年將達到 32.8 億美元,從 2026 年的 34.6 億美元成長到 2034 年的 54.5 億美元,2026 年至 2034 年的複合年成長率為 5.83%。北美憑藉先進的產科醫療基礎設施和強力的法律規範,在 2025 年引領全球市場,佔 34.48% 的市場佔有率。

胎兒監護設備用於懷孕和分娩過程中,以評估胎兒心率、子宮收縮、胎動和胎兒整體健康狀況。這些系統對於識別胎兒窘迫、指導產科介入以及最大限度減少分娩不良結局至關重要。高齡生產比例的增加、高危險妊娠的增加、剖腹產率的上升以及對即時產程監護的需求是推動市場擴張的主要因素。此外,攜帶式、無線和非侵入性監護解決方案的推出也增強了市場成長前景。

市場動態

市場促進因素

高危險妊娠病例的增加正在推動市場成長。

由於孕婦年齡、懷孕糖尿病、高血壓、妊娠毒血症以及體外受精(IVF)等輔助生殖技術等因素,高風險懷孕的數量正在增加。高風險妊娠需要頻繁且持續地進行胎心率監測,以便及早發現併發症。根據克利夫蘭診所統計,美國每年約有6%至8%的懷孕被歸類為高風險懷孕。

醫院正在將子宮內胎心率監測(CTG)標準化,以便及時介入並降低新生兒發病率。這種臨床需求推動了對CTG監視器、遙測系統和先進胎兒感測器的需求。

市場限制因素

關於非侵入式連續監測的監管和準確性問題

穿戴式非侵入性胎兒分娩監視器正日益普及,但其訊號準確性以及區分母體和胎兒心率的能力仍面臨監管審查。誤報可能導致不必要的醫療干預,例如緊急剖腹產。此外,先進的胎心監測(CTG)和無線遠端檢測系統高成本,限制了其在小規模婦產科機構和低收入地區的普及。

市場機遇

人工智慧與決策支援分析的融合

以人工智慧為基礎的胎兒監護平台能夠分析心率變異性和宮縮模式,展現出巨大的成長潛力。這些解決方案能夠減少醫護人員診斷的差異,並提高胎兒窘迫的早期檢出率。雲端連線支援遠端產科醫生診斷和即時警報。提供整合硬體、無線貼片和人工智慧分析功能的供應商,在贏得高價值醫院合約方面佔優勢。

市場挑戰

誤報與臨床責任

持續胎心監測(CTG)常產生臨床意義不大、「不可靠」的波形。這可能導致決策過於謹慎,並可能增加剖腹產率。醫院必須在安全性和不必要的干涉之間取得平衡。高體重指數(BMI)患者以及活動期間的訊號中斷也會帶來操作上的挑戰。

市場趨勢

向非侵入式和無線監測過渡

一個關鍵趨勢是從傳統的腰帶式監視器轉向無線貼片式系統,以提高產婦在分娩期間的活動能力。無線遙測技術使患者能夠在保持持續監測的同時自由行走。

例如,2024 年 2 月,GE Healthcare 的 Novii+ 無線母胎監護解決方案獲得了美國 FDA 的 510(k) 批准,該解決方案旨在支持產前和產中監護的移動性。

細分分析

透過方法

市場區隔方法分為侵入式方法和非侵入式方法。

  • 由於其安全性和降低感染風險,非侵入性治療在 2024 年佔了市場主導地位,預計到 2026 年將佔市場佔有率的 67.77%。
  • 預計到 2034 年,侵入性治療領域將以 4.6% 的複合年成長率成長。

副產品

此部分包括設備和耗材。

  • 預計到 2025 年,耗材細分市場將以 62.3% 的市佔率領先,到 2026 年將達到 64.84%,這主要得益於其較高的更換頻率。
  • 預計市場將以 5.1% 的複合年成長率成長。

透過使用

該市場包括產前和產中監測。

  • 預計到 2025 年,子宮內監測(透過在分娩過程中進行持續監測)將佔市場主導地位,市場佔有率達到 54.3%,到 2026 年將保持 53.99% 的市場佔有率。
  • 預計產前監測將以 6.3% 的複合年成長率成長。

最終用戶

該部分包括醫院、居家照護機構、診斷中心等。

  • 醫院在市場中佔主導地位,預計到 2026 年將佔市場 75.76% 的佔有率。
  • 預計居家照護環境將以 6.6% 的複合年成長率成長。

區域展望

北美洲

預計北美將保持其主導地位,在2025年市場規模將達到11.3億美元,在2026年將達到11.9億美元,這主要得益於先進胎兒監護技術的積極應用。

歐洲

在健全的產前護理標準和感染預防通訊協定的支持下,預計到 2026 年,歐洲的產婦保健市場規模將達到 9.5 億美元。

亞太地區

亞太地區預計將以最高的複合年成長率成長,到 2026 年達到 10.5 億美元,這主要得益於中國和印度醫療保健投資的增加。

拉丁美洲、中東和非洲

由於醫療基礎設施的改善和孕產婦健康意識的提高,預計這些地區將逐步實現成長。

目錄

第1章:引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章:主要考慮因素

  • 2024/2025年主要國家和地區主要疾病的流行情況
  • 胎兒監測技術的進步
  • 新產品發布,主要企業
  • 產業重大發展:合併、收購與合作。

第5章:2021-2034年全球胎兒監護市場分析、洞察與預測

  • 市場分析、洞察與預測:依方法論分類
    • 侵入性
    • 非侵入性
  • 市場分析、洞察與預測:依產品分類。
    • 消耗品
      • 電極
      • 超音波凝膠和耦合劑
      • 一次性感測器
      • 其他
    • 裝置
      • 超音波胎兒分娩監視器
      • 電子胎兒分娩監視器(EFM)
      • 胎兒多普勒
      • 其他
  • 市場分析、洞察與預測:依應用領域分類
    • 產前監測
    • 勞動監控
  • 市場分析、洞察與預測:依最終用戶分類
    • 醫院
    • 居家醫療環境
    • 診斷和影像中心
    • 其他
  • 市場分析、洞察與預測:依地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章:北美胎兒監測市場分析、洞察與預測(2021-2034年)

  • 國家
    • 美國
    • 加拿大

第7章:歐洲胎兒監護市場分析、洞察與預測(2021-2034年)

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章:亞太地區胎兒監護市場分析、洞察與預測(2021-2034年)

  • 國家
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 其他亞太國家

第9章:拉丁美洲胎兒監護市場分析、洞察與預測(2021-2034年)

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章:中東和非洲胎兒監護市場分析、洞察與預測(2021-2034年)

  • 國家
    • 南非
    • GCC
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析(2025 年)
  • 公司簡介
    • GE HealthCare Technologies Inc.
    • Koninklijke Philips NV
    • Mindray Medical International Ltd.
    • Nihon Kohden Corporation
    • Analogic Corporation
    • Huntleigh Healthcare Limited
    • Bionet Co., Ltd.
    • Edan Instruments, Inc.
    • Spacelabs Healthcare
    • Dragerwerk AG & Co. KGaA
Product Code: FBI114460

Growth Factors of fetal monitoring Market

The global fetal monitoring market was valued at USD 3.28 billion in 2025 and is projected to grow from USD 3.46 billion in 2026 to USD 5.45 billion by 2034, registering a CAGR of 5.83% during 2026-2034. North America dominated the global market with a 34.48% share in 2025, supported by advanced obstetric care infrastructure and strong regulatory oversight.

Fetal monitoring devices are used to evaluate fetal heart rate, uterine contractions, fetal movement, and overall fetal well-being during pregnancy and labor. These systems are critical in identifying fetal distress, guiding obstetric intervention, and minimizing adverse birth outcomes. Rising maternal age, increasing high-risk pregnancies, growing cesarean section rates, and demand for real-time labor monitoring are key contributors to market expansion. Additionally, adoption of portable, wireless, and non-invasive monitoring solutions is strengthening growth prospects.

Market Dynamics

Market Drivers

Rising Rate of High-Risk Pregnancies to Support Market Growth

An increasing number of pregnancies are categorized as high-risk due to maternal age, gestational diabetes, hypertension, preeclampsia, and assisted reproductive technologies such as IVF. High-risk cases require frequent and often continuous fetal heart rate monitoring to detect complications early. According to the Cleveland Clinic, approximately 6-8% of pregnancies in the U.S. are high-risk annually.

Hospitals are standardizing cardiotocography (CTG) during labor to enable timely intervention and reduce neonatal morbidity. This clinical necessity is driving demand for CTG monitors, telemetry systems, and advanced fetal transducers.

Market Restraints

Regulatory and Accuracy Concerns in Non-Invasive Continuous Monitoring

Although wearable and non-invasive fetal monitors are gaining popularity, they face regulatory scrutiny regarding signal accuracy and differentiation between maternal and fetal heart rates. False alarms may lead to unnecessary interventions such as emergency C-sections. Additionally, high costs of advanced CTG and wireless telemetry systems limit adoption in smaller maternity centers and low-income regions.

Market Opportunities

Integration of AI and Decision-Support Analytics

AI-based fetal monitoring platforms that interpret heart rate variability and contraction patterns present strong growth opportunities. These solutions reduce inter-clinician variability and improve early detection of fetal distress. Cloud-based connectivity enables remote obstetric review and real-time alerts. Vendors offering integrated hardware, wireless patches, and AI-powered analytics are well-positioned to secure higher-value hospital contracts.

Market Challenges

False Alarms and Clinical Liability

Continuous CTG monitoring often generates "non-reassuring" tracings that are not clinically significant. This may increase defensive decision-making and raise C-section rates. Hospitals must balance safety with unnecessary intervention. Signal dropouts in patients with higher BMI or during movement also pose operational challenges.

Market Trends

Shift Toward Non-Invasive and Wireless Monitoring

A major trend is the shift from traditional belt-based monitors to wireless and patch-based systems that enhance maternal mobility during labor. Wireless telemetry allows patients to ambulate freely while maintaining continuous monitoring.

For instance, in February 2024, GE HealthCare received U.S. FDA 510(k) clearance for its Novii+ Wireless Maternal and Fetal Monitoring Solution, designed to support mobility during antepartum and intrapartum monitoring.

Segmentation Analysis

By Method

The market is segmented into invasive and non-invasive methods.

  • The non-invasive segment dominated in 2024 and is projected to account for 67.77% of the market in 2026, due to safety and reduced infection risk.
  • The invasive segment is expected to grow at a CAGR of 4.6% through 2034.

By Product

Segments include instruments and consumables.

  • The consumables segment led the market with 62.3% share in 2025 and is projected to account for 64.84% in 2026, driven by high replacement frequency.
  • Instruments are projected to grow at a CAGR of 5.1%.

By Application

The market includes antepartum and intrapartum monitoring.

  • Intrapartum monitoring dominated with 54.3% share in 2025 and is expected to hold 53.99% in 2026, due to continuous monitoring during labor.
  • Antepartum monitoring is expected to grow at a CAGR of 6.3%.

By End User

Hospitals, home care settings, diagnostic centers, and others comprise the segment.

  • Hospitals dominated and are projected to account for 75.76% of the market in 2026.
  • Home care settings are expected to grow at a CAGR of 6.6%.

Regional Outlook

North America

North America generated USD 1.13 billion in 2025 and USD 1.19 billion in 2026, maintaining leadership due to strong adoption of advanced fetal monitoring technologies.

Europe

Europe is projected to reach USD 0.95 billion in 2026, supported by strong pre-birth care standards and infection prevention protocols.

Asia Pacific

Asia Pacific is expected to grow at the fastest CAGR, reaching USD 1.05 billion in 2026, driven by rising healthcare investments in China and India.

Latin America and Middle East & Africa

These regions are projected to witness moderate growth due to improving healthcare infrastructure and increasing maternal health awareness.

Competitive Landscape

The market is moderately consolidated with leading players such as Philips Healthcare, GE HealthCare, Mindray Medical, Huntleigh Healthcare (Arjo), and Monica Healthcare. Companies emphasize clinical accuracy, wireless connectivity, AI-assisted interpretation, and patient comfort to strengthen market position. Strategic partnerships, FDA approvals, and expansion into remote monitoring solutions remain key competitive strategies.

Conclusion

The global fetal monitoring market is projected to grow from USD 3.28 billion in 2025 to USD 5.45 billion by 2034, expanding at a CAGR of 5.83%. Rising high-risk pregnancies, technological advancements in wireless and AI-enabled monitoring, and increasing emphasis on safe childbirth practices are key growth drivers. While regulatory scrutiny and false alarm challenges persist, innovation in non-invasive, connected, and decision-support systems is expected to sustain long-term market expansion through 2034.

Segmentation By Method

  • Invasive
  • Non-Invasive

By Product

  • Consumables
    • Electrodes
    • Ultrasound Gel & Couplants
    • Disposable Sensors
    • Others
  • Instrument
    • Ultrasound Fetal Monitors
    • Electronic Fetal Monitors (EFM)
    • Fetal Dopplers
    • Others

By Application

  • Antepartum Monitoring
  • Intrapartum Monitoring

By End-User

  • Hospitals
  • Home Care Settings
  • Diagnostic & Imaging Centers
  • Others

By Region

  • North America (By Method, Product, Application, End-User, and Country)
    • U.S.
      • By Product
    • Canada
      • By Product
  • Europe (By Method, Product, Application, End-User, and Country/Sub-region)
    • Germany
      • By Product
    • U.K.
      • By Product
    • France
      • By Product
    • Spain
      • By Product
    • Italy
      • By Product
    • Scandinavia
      • By Product
    • Rest of Europe
      • By Product
  • Asia Pacific (By Method, Product, Application, End-User, and Country/Sub-region)
    • China
      • By Product
    • Japan
      • By Product
    • India
      • By Product
    • Australia
      • By Product
    • Southeast Asia
      • By Product
    • Rest of Asia Pacific
      • By Product
  • Latin America (By Method, Product, Application, End-User, and Country/Sub-region)
    • Brazil
      • By Product
    • Mexico
      • By Product
    • Rest of Latin America
      • By Product
  • Middle East & Africa (By Method, Product, Application, End-User, and Country/Sub-region)
    • GCC
      • By Product
    • South Africa
      • By Product
    • Rest of Middle East & Africa
      • By Product

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2024/2025
  • 4.2. Technological Advancements in Fetal Monitoring
  • 4.3. New Product Launches, Key Players
  • 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Fetal Monitoring Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Method
    • 5.1.1. Invasive
    • 5.1.2. Non-Invasive
  • 5.2. Market Analysis, Insights and Forecast - By Product
    • 5.2.1. Consumables
      • 5.2.1.1. Electrodes
      • 5.2.1.2. Ultrasound Gel & Couplants
      • 5.2.1.3. Disposable Sensors
      • 5.2.1.4. Others
    • 5.2.2. Instrument
      • 5.2.2.1. Ultrasound Fetal Monitors
      • 5.2.2.2. Electronic Fetal Monitors (EFM)
      • 5.2.2.3. Fetal Dopplers
      • 5.2.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Antepartum Monitoring
    • 5.3.2. Intrapartum Monitoring
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals
    • 5.4.2. Home Care Settings
    • 5.4.3. Diagnostic & Imaging Centers
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Fetal Monitoring Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Method
    • 6.1.1. Invasive
    • 6.1.2. Non-Invasive
  • 6.2. Market Analysis, Insights and Forecast - By Product
    • 6.2.1. Consumables
      • 6.2.1.1. Electrodes
      • 6.2.1.2. Ultrasound Gel & Couplants
      • 6.2.1.3. Disposable Sensors
      • 6.2.1.4. Others
    • 6.2.2. Instrument
      • 6.2.2.1. Ultrasound Fetal Monitors
      • 6.2.2.2. Electronic Fetal Monitors (EFM)
      • 6.2.2.3. Fetal Dopplers
      • 6.2.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Antepartum Monitoring
    • 6.3.2. Intrapartum Monitoring
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals
    • 6.4.2. Home Care Settings
    • 6.4.3. Diagnostic & Imaging Centers
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Method
    • 6.5.2. Canada
      • 6.5.2.1. By Method

7. Europe Fetal Monitoring Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Method
    • 7.1.1. Invasive
    • 7.1.2. Non-Invasive
  • 7.2. Market Analysis, Insights and Forecast - By Product
    • 7.2.1. Consumables
      • 7.2.1.1. Electrodes
      • 7.2.1.2. Ultrasound Gel & Couplants
      • 7.2.1.3. Disposable Sensors
      • 7.2.1.4. Others
    • 7.2.2. Instrument
      • 7.2.2.1. Ultrasound Fetal Monitors
      • 7.2.2.2. Electronic Fetal Monitors (EFM)
      • 7.2.2.3. Fetal Dopplers
      • 7.2.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Antepartum Monitoring
    • 7.3.2. Intrapartum Monitoring
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals
    • 7.4.2. Home Care Settings
    • 7.4.3. Diagnostic & Imaging Centers
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
      • 7.5.1.1. By Method
    • 7.5.2. Germany
      • 7.5.2.1. By Method
    • 7.5.3. France
      • 7.5.3.1. By Method
    • 7.5.4. Spain
      • 7.5.4.1. By Method
    • 7.5.5. Italy
      • 7.5.5.1. By Method
    • 7.5.6. Scandinavia
      • 7.5.6.1. By Method
    • 7.5.7. Rest of Europe
      • 7.5.7.1. By Method

8. Asia Pacific Fetal Monitoring Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Method
    • 8.1.1. Invasive
    • 8.1.2. Non-Invasive
  • 8.2. Market Analysis, Insights and Forecast - By Product
    • 8.2.1. Consumables
      • 8.2.1.1. Electrodes
      • 8.2.1.2. Ultrasound Gel & Couplants
      • 8.2.1.3. Disposable Sensors
      • 8.2.1.4. Others
    • 8.2.2. Instrument
      • 8.2.2.1. Ultrasound Fetal Monitors
      • 8.2.2.2. Electronic Fetal Monitors (EFM)
      • 8.2.2.3. Fetal Dopplers
      • 8.2.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Antepartum Monitoring
    • 8.3.2. Intrapartum Monitoring
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals
    • 8.4.2. Home Care Settings
    • 8.4.3. Diagnostic & Imaging Centers
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
      • 8.5.1.1. By Method
    • 8.5.2. Australia
      • 8.5.2.1. By Method
    • 8.5.3. China
      • 8.5.3.1. By Method
    • 8.5.4. India
      • 8.5.4.1. By Method
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Method
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Method

9. Latin America Fetal Monitoring Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Method
    • 9.1.1. Invasive
    • 9.1.2. Non-Invasive
  • 9.2. Market Analysis, Insights and Forecast - By Product
    • 9.2.1. Consumables
      • 9.2.1.1. Electrodes
      • 9.2.1.2. Ultrasound Gel & Couplants
      • 9.2.1.3. Disposable Sensors
      • 9.2.1.4. Others
    • 9.2.2. Instrument
      • 9.2.2.1. Ultrasound Fetal Monitors
      • 9.2.2.2. Electronic Fetal Monitors (EFM)
      • 9.2.2.3. Fetal Dopplers
      • 9.2.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Antepartum Monitoring
    • 9.3.2. Intrapartum Monitoring
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals
    • 9.4.2. Home Care Settings
    • 9.4.3. Diagnostic & Imaging Centers
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
      • 9.5.1.1. By Method
    • 9.5.2. Mexico
      • 9.5.2.1. By Method
    • 9.5.3. Rest of Latin America
      • 9.5.3.1. By Method

10. Middle East &Africa Fetal Monitoring Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Method
    • 10.1.1. Invasive
    • 10.1.2. Non-Invasive
  • 10.2. Market Analysis, Insights and Forecast - By Product
    • 10.2.1. Consumables
      • 10.2.1.1. Electrodes
      • 10.2.1.2. Ultrasound Gel & Couplants
      • 10.2.1.3. Disposable Sensors
      • 10.2.1.4. Others
    • 10.2.2. Instrument
      • 10.2.2.1. Ultrasound Fetal Monitors
      • 10.2.2.2. Electronic Fetal Monitors (EFM)
      • 10.2.2.3. Fetal Dopplers
      • 10.2.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Antepartum Monitoring
    • 10.3.2. Intrapartum Monitoring
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals
    • 10.4.2. Home Care Settings
    • 10.4.3. Diagnostic & Imaging Centers
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. South Africa
      • 10.5.1.1. By Method
    • 10.5.2. GCC
      • 10.5.2.1. By Method
    • 10.5.3. Rest of Middle East & Africa
      • 10.5.3.1. By Method

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. GE HealthCare Technologies Inc.
    • 11.2.2. Koninklijke Philips N.V.
    • 11.2.3. Mindray Medical International Ltd.
    • 11.2.4. Nihon Kohden Corporation
    • 11.2.5. Analogic Corporation
    • 11.2.6. Huntleigh Healthcare Limited
    • 11.2.7. Bionet Co., Ltd.
    • 11.2.8. Edan Instruments, Inc.
    • 11.2.9. Spacelabs Healthcare
    • 11.2.10. Dragerwerk AG & Co. KGaA

List of Tables

  • Table 1: Global Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 2: Global Fetal Monitoring Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 3: Global Fetal Monitoring Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 4: Global Fetal Monitoring Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 5: Global Fetal Monitoring Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 7: North America Fetal Monitoring Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 8: North America Fetal Monitoring Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 9: North America Fetal Monitoring Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 10: North America Fetal Monitoring Market Revenue (USD billion) Forecast, by Country, 2021-2034
  • Table 11: U.S. Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 12: Canada Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 13: Europe Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 14: Europe Fetal Monitoring Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 15: Europe Fetal Monitoring Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 16: Europe Fetal Monitoring Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 17: Europe Fetal Monitoring Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 18: U.K. Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 19: Germany Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 20: France Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 21: Spain Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 22: Italy Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 23: Scandinavia Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 24: Rest of Europe Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 25: Asia Pacific Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 26: Asia Pacific Fetal Monitoring Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 27: Asia Pacific Fetal Monitoring Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 28: Asia Pacific Fetal Monitoring Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 29: Asia Pacific Fetal Monitoring Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 30: Japan Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 31: Australia Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 32: China Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 33: India Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 34: South East Asia Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 35: Rest of Asia Pacific Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 36: Latin America Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 37: Latin America Fetal Monitoring Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 38: Latin America Fetal Monitoring Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 39: Latin America Fetal Monitoring Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 40: Latin America Fetal Monitoring Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 41: Brazil Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 42: Mexico Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 43: Rest of Latin America Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 44: Middle East & Africa Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 45: Middle East & Africa Fetal Monitoring Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 46: Middle East & Africa Fetal Monitoring Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 47: Middle East & Africa Fetal Monitoring Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 48: Middle East & Africa Fetal Monitoring Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 49: GCC Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 50: South Africa Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034
  • Table 51: Rest of Middle East & Africa Fetal Monitoring Market Revenue (USD billion) Forecast, By Method, 2021-2034

List of Figures

  • Figure 1: Global Fetal Monitoring Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Fetal Monitoring Market Value Share (%), By Method, 2025 & 2034
  • Figure 3: Global Fetal Monitoring Market Value Share (%), By Product, 2025 & 2034
  • Figure 4: Global Fetal Monitoring Market Value Share (%), by Application, 2025 & 2034
  • Figure 5: Global Fetal Monitoring Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: Global Fetal Monitoring Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Fetal Monitoring Market Value (USD billion), By Method, 2025 & 2034
  • Figure 8: North America Fetal Monitoring Market Value Share (%), By Method, 2025
  • Figure 9: North America Fetal Monitoring Market Value (USD billion), By Product, 2025 & 2034
  • Figure 10: North America Fetal Monitoring Market Value Share (%), By Product, 2025
  • Figure 11: North America Fetal Monitoring Market Value (USD billion), by Application, 2025 & 2034
  • Figure 12: North America Fetal Monitoring Market Value Share (%), by Application, 2025
  • Figure 13: North America Fetal Monitoring Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 14: North America Fetal Monitoring Market Value Share (%), by End-user, 2025
  • Figure 15: North America Fetal Monitoring Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Fetal Monitoring Market Value Share (%), By Country, 2025
  • Figure 17: Europe Fetal Monitoring Market Value (USD billion), By Method, 2025 & 2034
  • Figure 18: Europe Fetal Monitoring Market Value Share (%), By Method, 2025
  • Figure 19: Europe Fetal Monitoring Market Value (USD billion), By Product, 2025 & 2034
  • Figure 20: Europe Fetal Monitoring Market Value Share (%), By Product, 2025
  • Figure 21: Europe Fetal Monitoring Market Value (USD billion), by Application, 2025 & 2034
  • Figure 22: Europe Fetal Monitoring Market Value Share (%), by Application, 2025
  • Figure 23: Europe Fetal Monitoring Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 24: Europe Fetal Monitoring Market Value Share (%), by End-user, 2025
  • Figure 25: Europe Fetal Monitoring Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 26: Europe Fetal Monitoring Market Value Share (%), By Country/Sub-region, 2025
  • Figure 27: Asia Pacific Fetal Monitoring Market Value (USD billion), By Method, 2025 & 2034
  • Figure 28: Asia Pacific Fetal Monitoring Market Value Share (%), By Method, 2025
  • Figure 29: Asia Pacific Fetal Monitoring Market Value (USD billion), By Product, 2025 & 2034
  • Figure 30: Asia Pacific Fetal Monitoring Market Value Share (%), By Product, 2025
  • Figure 31: Asia Pacific Fetal Monitoring Market Value (USD billion), by Application, 2025 & 2034
  • Figure 32: Asia Pacific Fetal Monitoring Market Value Share (%), by Application, 2025
  • Figure 33: Asia Pacific Fetal Monitoring Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 34: Asia Pacific Fetal Monitoring Market Value Share (%), by End-user, 2025
  • Figure 35: Asia Pacific Fetal Monitoring Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Fetal Monitoring Market Value Share (%), By Country/Sub-region, 2025
  • Figure 37: Latin America Fetal Monitoring Market Value (USD billion), By Method, 2025 & 2034
  • Figure 38: Latin America Fetal Monitoring Market Value Share (%), By Method, 2025
  • Figure 39: Latin America Fetal Monitoring Market Value (USD billion), By Product, 2025 & 2034
  • Figure 40: Latin America Fetal Monitoring Market Value Share (%), By Product, 2025
  • Figure 41: Latin America Fetal Monitoring Market Value (USD billion), by Application, 2025 & 2034
  • Figure 42: Latin America Fetal Monitoring Market Value Share (%), by Application, 2025
  • Figure 43: Latin America Fetal Monitoring Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 44: Latin America Fetal Monitoring Market Value Share (%), by End-user, 2025
  • Figure 45: Latin America Fetal Monitoring Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 46: Latin America Fetal Monitoring Market Value Share (%), By Country/Sub-region, 2025
  • Figure 47: Middle East & Africa Fetal Monitoring Market Value (USD billion), By Method, 2025 & 2034
  • Figure 48: Middle East & Africa Fetal Monitoring Market Value Share (%), By Method, 2025
  • Figure 49: Middle East & Africa Fetal Monitoring Market Value (USD billion), By Product, 2025 & 2034
  • Figure 50: Middle East & Africa Fetal Monitoring Market Value Share (%), By Product, 2025
  • Figure 51: Middle East & Africa Fetal Monitoring Market Value (USD billion), by Application, 2025 & 2034
  • Figure 52: Middle East & Africa Fetal Monitoring Market Value Share (%), by Application, 2025
  • Figure 53: Middle East & Africa Fetal Monitoring Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 54: Middle East & Africa Fetal Monitoring Market Value Share (%), by End-user, 2025
  • Figure 55: Middle East & Africa Fetal Monitoring Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Fetal Monitoring Market Value Share (%), By Country/Sub-region, 2025
  • Figure 57: Global Fetal Monitoring Market Share (%), By Company, 2025